Checkmate Capital Group Completes Seed Investment in Lactiga, Inc.
PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company developing...
NeuroSigma Receives Bridge Financing from Checkmate Capital
To Support Targeted Commercialization and Global Partnering of FDA-Approved Non-Drug Treatment for Pediatric ADHD LOS ANGELES, Sept. 21,...
Monarch Biosciences Closes Seed Round Financing
Led by Checkmate Capital Group Development of Biomaterial-based Neurovascular Stent and Platform for Local Delivery of Cell Therapies LOS...
Checkmate Capital Group Announces Opening of New Corporate Office in Pasadena, California
LOS ANGELES, March 16, 2020 (GLOBE NEWSWIRE) -- Checkmate Capital Group, LLC (“Checkmate”) is pleased to announce that it is moving its...